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Abstract: Direct reprogramming of pancreatic beta cells is of great interest due to its possible use in diabetes treatment. Various
studies have demonstrated direct reprogramming of insulin expressing beta cells from other somatic cells by overexpressing important
pancreatic transcription factors through viral vectors. However, concerns about using viral vectors in the clinic have prompted scientists
to find new approaches for gene delivery and expression. In vitro synthesis and transfection of mRNAs is a safer strategy for ectopic
gene expression. In this study we aimed to design and in vitro synthesize human pancreatic transcription factors’ mRNAs: Pdx1, Ngn3,
and MafA. We also aimed to assess their expression efficiency in cultured cells. First we ligated the open reading frames of these genes
to modified 5′ and 3′ UTRs. Ligation products were then cloned into a plasmid and subjected to in vitro transcription to get their
corresponding mRNAs. Modified mRNAs were subsequently examined for their quality, quantity, and protein translation efficiency.
In vitro-transcribed mRNAs were successfully transfected to the human fibroblast cells. Efficiently translated proteins were correctly
localized into the nucleus. It is concluded that pancreatic mRNAs designed and in vitro-transcribed in this study can be used in further
direct beta cell reprogramming studies.
Key words: Direct cell reprogramming, Pdx1, Ngn3, MafA, synthetic mRNA, in vitro transcription

1. Introduction
Direct reprogramming of differentiated mature cells into
each other is of great importance as it provides a short cut to
create a cell line of interest while eliminating the necessity
for an intermediate pluripotent state. Somatic cells can be
directly reprogrammed into each other by either using
small molecules (Hu et al., 2015; Cao et al., 2016) or
expressing the master transcription factors ectopically
in target cells (Caiazzo et al., 2011; Su et al., 2014). Viral
vector systems are common molecular tools to express
master transcription factor genes in reprogramming
studies as the viral vectors can transfect a wide variety of
mammalian cell types and can highly express the genes of
interest that they carry with low toxicity in the transfected
cells (Li et al., 2013). However, the use of viral vectors in
medical applications presents some concerns because
of their potential to alter the host genome by random
integration of viral genes into the host genome (Fischer et
al., 2011). Immunogenicity produced by viral proteins is
another problem limiting the use of viral vectors (Thacker
et al., 2009). Retroviral vectors do integrate into the host
DNA to replicate and express the genes that they carry.
Unlike retroviruses, adenoviruses remain in the cytoplasm
of the transfected cells as a separate plasmid particle and
* Correspondence: ersinakinci@akdeniz.edu.tr
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do not need to integrate into the host DNA for expression
of their genes. However, there is always a risk of adenoviral
DNA integration into the host DNA by recombination.
Depending on the integration site, viral DNA fragments
integrated into host DNA can cause malignancy. The risk
of host genome alteration and its possible carcinogenic
effects due to viral vectors made scientists look for a
new approach that is not a viral or DNA-based system to
carry and express the genes of interest in the cells to be
reprogrammed (Li et al., 2013). Transfection of in vitrosynthesized mRNAs of master transcription factors into
target cells is an alternative strategy for gene delivery.
mRNA transfection can be considered a safer method
compared to DNA-based vectors as there is no chance for
recombination of mRNA into the DNA. Synthetic mRNA
transfection is also more advantageous than recombinant
protein delivery as it avoids the time and cost-consuming
of recombinant protein production, purification, and
delivery. After their transfection synthetic mRNAs can
be directly translated into functional proteins in the
cytoplasm of recipient cells. They will also acquire proper
posttranslational protein modifications, which will result
in production of more functional proteins compared to
those produced in bacterial expression systems. There are
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various studies showing that in vitro-synthesized mRNAs
can be efficiently delivered into target cells and provide
a proper translation of their corresponding proteins
(Boczkowski et al., 2009; Plews et al., 2010; Warren et al.,
2010; Yakubov et al., 2010). However, after transfection,
in vitro-synthesized mRNAs are recognized as viral
RNAs by host cells. As the result, a strong interferon
reaction is initiated in host cells, which eventually results
in cell arrest and/or cell death. To escape from this innate
immune system of the host cells some modifications
should be applied during in vitro transcription (IVT) of
synthetic mRNAs. For instance, i) use of pseudouridine
(psi) (Kariko et al., 2008) and 5-methylcytidine (5mC)
instead of uridine and cytidine respectively during the
IVT reaction, ii) phosphatase treatment of synthesized
mRNAs to remove free phosphate groups from the 5′
end of uncapped mRNAs after the IVT reaction, and iii)
adding B18R recombinant protein (a type-I interferon
binding protein that inhibits IFN response) in the culture
medium of host cells are some of these modifications.
Pancreatic beta cells are a medically important cell
type because their loss due to an auto-immune attack
causes diabetes, a serious metabolic disease characterized
by hyperglycemia. Drawbacks of the current treatments
of diabetes necessitate creating a new beta cell source.
Direct reprogramming of other mature somatic cells into
beta cells is an alternative strategy to find a new treatment
for diabetes. Production of insulin positive beta-like cells
was shown in various studies in which some important
pancreatic transcription factor genes such as Pdx1, Ngn3,
and MafA were overexpressed in host cells through DNAbased vector systems (Zhou et al., 2008; Akinci et al., 2012;
Banga et al., 2012; Yang et al., 2013).
The aim of the present study was to find a suitable
condition to ameliorate glucose dependent insulin
secreting pancreatic beta cell generation through mRNA
transfection of important pancreatic transcription factors
to human mature somatic cells. To achieve our goal, we
devoted effort to in vitro synthesize mRNAs of three
important human pancreatic transcription factors (Pdx1,
Ngn3, and MafA) to be transfected into human skin
fibroblast (BJ) cells. We then assessed the transfection

by examining the expression of the synthetic mRNAs
inside the cells and their translation to the corresponding
functional proteins. This study will be a preliminary step
to attain our fundamental purpose of beta cell generation
betterment.
2. Materials and methods
2.1. Designing of double strand template DNA
Human Pdx1, Ngn3, and MafA cDNAs were purchased
(OriGene, Rockville, MD, USA) and open reading frames
(ORFs) of each cDNA were amplified through polymerase
chain reaction (PCR) using ORF primers (Table 1).
PCR conditions were as follows: 98 °C for 30 s initial
denaturation, 98 °C for 10 s denaturation, 60 °C for 30
s annealing, 72 °C for 1 min extension, 72 °C for 5 min
final extension, and overall 30 cycles were performed. PCR
products were run on an agarose gel including GelStar
dye (Lonza, Basel, Switzerland) and were visualized by
PrepOne Sapphire blue light box (EmbiTec, San Diego,
CA, USA). DNA bands at expected size were cut out and
purified using a gel extraction kit (Thermo Scientific,
Waltham, MA, USA). ORFs were then ligated to 5′ and 3′
untranslated regions (UTRs) (Table 2) by using Ampligase
thermostable DNA ligase (Epicentre, Madison, WI, USA)
and splint oligo primers (Table 2) as adapter fragments.
Ligation conditions were as follows: 95 °C for 10 s
denaturation, 45 °C for 60 s, 50 °C for 60 s, 55 °C for 60
s annealing, and overall 5 cycles were performed. UTRligated cDNAs were amplified by using template primers
(Table 2). PCR conditions were as follows: 98 °C for 30
s initial denaturation, 98 °C for 10 s denaturation, 60 °C
for 30 s annealing, 72 °C for 1 min extension, 72 °C for 5
min final extension, and overall 35 cycles were performed.
UTRs ligation was visualized by blue light box on agarose
gel including GelStar dye. DNA bands at expected size
were extracted and purified. Ligation products were
cloned into a blunt end vector (pJET1.2/blunt) (Thermo
Scientific) and sent to Macrogen Company (Amsterdam,
Netherlands) for DNA sequencing. Plasmids carrying
UTR-ligated cDNAs were then linearized by SalI digestion.
Poly(T) tails were added to the linearized template through
a PCR by using tail primers (Table 2). PCR conditions

Table 1. Primers used to amplify ORFs of the genes of interest.
Gene (accession no.)
Pdx1 (NM_000209.3)
Ngn3 (NM_020999.3)
MafA (NM_201589.3)

ORF primers (5’–3’)
F: AACGGCGAGGAGCAGTA (including 5’ phosphate)
R: TCATCGTGGTTCCTGCGG
F: ACGCCTCAACCCTCG (including 5’ phosphate)
R: TCACAGAAAATCTGAGAAAGCC
F: GCCGCGGAGCTGGCGATGGGCGCC (including 5’ phosphate)
R: CTACAGGAAGAAGTCGGCCGTGCC
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Table 2. UTRs and splint oligos used for ligation reactions.
Pdx1
5′-Splint
3′-Splint
Ngn3
5′-Splint
3′-Splint
MafA
5′-Splint
3′-Splint
5′-UTR

GTACTGCTCCTCGCCCTTCATGGTGGCTCTTATATTTCTTCTTACTCTTCT
CCCGCAGAAGGCAGCTCATCGTGGTTCCTGCGGCCG
ACCCGAGGGTTGAGGCGTCATGGTGGCTCTTATATTTCTTCTT
CCCGCAGAAGGCAGCTCACAGAAAATCTGAGAAAGC
CATCGCCAGCTCCGCGGCCATGGTGGCTCTTATATTTCTTCTT
CCCGCAGAAGGCAGCCTACAGGAAGAAGTCGGCCGT
TTGGACCCTCGTACAGAAGCTAATACGACTCACTATAGGGAAAT
AAGAGAGAAAAGAAGAGTAAGAAGAAATATAAGAGCCACCATG
(Warren et al., 2010)

3′-UTR

GCTGCCTTCTGCGGGGCTTGCCTTCTGGCCATGCCCTTCTTCTCT
CCCTTGCACCTGTACCTCTTGGTCTTTGAATAAAGCCTGAGTAGGAAG
TGAGGGTCTAGAACTAGTGTCGACGC (including 5’ phosphate) (Warren et al., 2010)

Template
primers

F: TTGGACCCTCGTACAGAAGCTAATACG
R: GCGTCGACACTAGTTCTAGACCCTCA

Tail primers

F: TTGGACCCTCGTACAGAAGCTAATACG
R: T(120)CTTCCTACTCAGGCTTTATTCAAAGACCA

were as follows: 95 °C for 3 min initial denaturation, 98
°C for 20 s denaturation, 60 °C for 15 s annealing, 72 °C
for 1 min extension, 72 °C for 3 min final extension, and
overall 30 cycles for Pdx1 and Ngn3 and 28 cycles for MafA
were performed. Poly(T) tail addition was visualized by a
UV-based gel imaging system on an agarose gel including
EtBr. Poly(T) tail-added PCR products were purified with
a PCR purification kit.
2.2. In vitro transcription (IVT) reaction
Pdx1, Ngn3, and MafA modified mRNAs were in
vitro-transcribed from poly(T) tail added and purified
PCR products by using an mMessage mMachine T7
transcription kit (Ambion, Austin, TX, USA). The IVT
reaction mixture was prepared as 40 µL including ~1–2 µg
of tailed PCR product, Anti Reverse Cap Analog (ARCA,
3′-O-Me-m7G(5′)ppp(5′)G) (Trilink, San Diego, CA,
USA), GTP, ATP, 5-methylcytidine (5-me-CTP) (Trilink),
and pseudouridine (pUTP) (Trilink). The IVT mixture
was incubated at 37 °C for 4 h and then was treated with
DNase at 37 °C for 15 min. The reaction was purified using
a MEGAclear transcription clean up kit (Ambion) as per
the manufacturer’s directions. The reaction mixture was
further treated with Antarctic phosphatase (NEB, Ipswich,
MA, USA) at 37 °C for 1 h and purified again. The quality
and quantity of the in vitro-transcribed RNAs (IVT RNAs)
were measured by NanoDrop spectrophotometer (Thermo
Scientific).
2.3. Cell culture and transfection with IVT RNAs
Human skin fibroblast (BJ) cells (ATCC, Manassas, VA,
USA) were plated (3 × 105/well) in 6-well plates (Corning,
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Corning, NY, USA) with growth medium comprising
high glucose DMEM (Gibco, Waltham, MA, USA), 10%
FBS (Gibco), 1X L-glutamine (Gibco), 1X NEAA (Gibco),
and 1X antibiotic-antimycotic (Gibco). The next day the
cells were transfected with IVT RNAs using lipofectamine
(Invitrogen, Carlsbad, CA, USA), which has a cationic
liposome formulation. The growth medium was replaced
with fresh medium containing 1:2400 B18R (Stemgent,
Cambridge, MA, USA) 12 h before transfection. For
transfection 3 µg of IVT RNA (30 µL) was mixed with
20 µL of Opti-MEM (Gibco). In a separate tube 15 µL of
lipofectamine was mixed with 35 µL of Opti-MEM. Both
mixtures were gently mixed together, incubated for 20 min
at room temperature, and added to cells dropwise. The
growth medium was replaced with fresh medium 6 h after
transfection.
2.4. Quantitative polymerase chain reaction (qPCR)
RNA isolation was performed 16 h after transfection by
using a Purelink RNA mini kit (Invitrogen) according
to the manufacturer’s directions. cDNAs were reverse
transcribed from 2 µg of RNA by using a Maxima first
strand cDNA synthesis kit (Thermo Scientific) as per the
manufacturer’s directions. cDNAs were then analyzed by
quantitative PCR in a Light Cycler 96 system (Roche, Basel,
Switzerland). The qPCR mixture was prepared as 20 µL
comprising KAPA SYBR FAST qPCR master mix (KAPA
Biosystems, Wilmington, MA, USA), forward and reverse
primers (Table 3), and ~20 ng of cDNA. qPCR conditions
were as follows: 95 °C for 3 min initial denaturation,
95 °C for 10 s denaturation, 60 °C for 30 s annealing/
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Table 3. Primers used for qPCR.
Gene

Forward primer (5′–3′)

Reverse primer (5′–3′)

Pdx1 endogenous

GGAACCACGATGAGAGGCAG

CCCAAGGTGGAGTGCTGTAG

Pdx1 exogenous

TTGGACCCTCGTACAGAAGC

CGCGTGAGCTTTGGTAGACT

Ngn3 endogenous

TCACCAAGATCGAGACGCTG

CCCTTACCCTTAGCACCCAC

Ngn3 exogenous

CCCTCGTACAGAAGCTAATACG

TCGATCTTGGTGAGCTTCGC

MafA endogenous

GTCATCCGGCTCAAGCAGAAG

GAGGCCTGCGCGAACTTGTC

MafA exogenous

TTGGACCCTCGTACAGAAGC

TTGAGGTGATGCTGGTAGCC

Gapdh

AGGGCTGCTTTTAACTCTGGT

CCCCACTTGATTTTGGAGGGA

extension, and overall 35 cycles were performed. Relative
quantification was calculated with 2−ΔΔCt and normalized
to Gapdh expression. The results were presented as related
expression level in BJ fibroblast cells.
2.5. Immunostaining
The cells were fixed 16 h after transfection using 10%
formalin (Sigma, St. Louis, MO, USA) for 10 min and were
permeabilized with 0.2% Triton X-100/PBS (Sigma) for 15
min. After permeabilization the cells were blocked with
1% BSA in 0.1% Tween-20/PBS for 1 h. The cells were then
incubated with primary and secondary antibodies (Table
4) overnight at 4 °C and for 1 h at room temperature,
respectively. Finally the cell nuclei were stained with
Hoechst (1:500) (Cell Signaling Technologies, Danvers,
MA, USA). The cells were then visualized under an
Olympus Axiovert inverted microscope (Olympus, Tokyo,
Japan). All washing, permeabilization and incubation steps
were carried out at room temperature unless indicated
otherwise.
2.6. Western blotting
Proteins were isolated 16 h after transfection from 106 cells
that were trypsinized and centrifuged to get a cell pellet.
Then 0.5 mL of RIPA buffer (Thermo Scientific) including

5 µL of PIC (Thermo Scientific) was added onto the cell
pellet. The cells were vortexed and centrifuged at 15,000
× g for 10 min at 4 °C. The supernatant was removed
from the debris and used for further experiments. Next
10% resolving and stacking gels were prepared. Laemmli
sample buffer was prepared and mixed with cell extracts
at 25 µL final volume. The mixture was boiled for 5
min and then chilled on ice for 2 min. The mixture was
loaded to gel and run in a Mini trans-blot cell system
(BioRad, Hercules, CA, USA). After overnight blotting at
4 °C, the membrane was incubated with I-Block blocking
reagent (Thermo Scientific) for 2 h at room temperature.
The membrane was then incubated with primary and
secondary antibodies (Table 4) diluted in I-Block for 4
h and 1 h, respectively, at 25 °C. SuperSignal West Pico
chemiluminescent substrate (Thermo Scientific) was used
for signaling and images were obtained by GeneGenome
system (Syngene, Cambridge, UK).
2.7. Cell viability assay
BJ cells were plated (1.5 × 104/well) into 96-well plates.
Each well was transfected with different IVT RNA (Pdx1,
Ngn3, and MafA) for 3 days; 110 ng of RNA/well was given
to the cells daily. Cells with no treatment and cells treated

Table 4. Primary and secondary antibodies used in immunostaining and western blotting.
Antibody

Brand

Dilution/experiment

Rb monoclonal anti-Pdx1

Abcam (ab134150)

1:200 for IF, 1:1000 for WB

Rb polyclonal anti-Ngn3

Abcam (ab38548)

1:200 for IF, 1:1000 for WB

Rb polyclonal anti-MafA

Abcam (ab26405)

1:200 for IF, 1:1000 for WB

Ms monoclonal anti-Beta actin

Abcam (ab6276)

1:5000 for WB

Gt anti-Rb IgG Dylight 488

Thermo Scientific (35552)

1:500 for IF

Gt anti-Rb IgG HRP conjugate

Thermo Scientific (31460)

1:3000 for WB

Gt anti-Ms IgG HRP conjugate

BioRad (170-6516)

1:5000 for WB

Rb: rabbit, Gt: goat, Ms: mouse, HRP: horseradish peroxidase, IF: immunofluorescence, WB: western blot
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with lipofectamine only were used as control lines. Cell
culture and RNA transfection was performed as described
previously. Viability of the cells was detected with a
CellTiter-Blue cell viability assay kit (Promega) according
to the manufacturer’s instructions. The absorbance at
560 nm was measured by Multiskan Go microplate
spectrophotometer (Thermo Scientific) at 24, 48, and 72 h.
3. Results
3.1. Construction of double strand DNA templates for
Pdx1, Ngn3, and MafA
For longer stability and proper translation, genes to be
in vitro-transcribed should be ligated to modified UTR
regions. For that reason, the first experiment performed
was the construction of dsDNA templates for IVT
reactions. The entire protocol describing the design of
dsDNA templates for Pdx1, Ngn3, and MafA is illustrated
in Figure 1A. To begin with, Pdx1, Ngn3, and MafA ORFs
were amplified by PCR and run on an agarose gel. Resulting
bands visualized by UV illumination were of expected
size: 849 bp for Pdx1, 643 bp for Ngn3, and 1059 bp for
MafA (Figure 1B). Upon ligation with 5′ UTR (87 bp) and
3′ UTR (119 bp), ligation products were also amplified by
PCR and run on an agarose gel. Resulting bands visualized
by UV illumination were of expected size: 1055 bp for
Pdx1, 849 bp for Ngn3, and 1265 bp for MafA (Figure 1C).
Poly(T) tails (T120) were then added to ligation products by
PCR and run on an agarose gel. Resulting bands visualized
by UV illumination verified the addition of 120 bp poly(T)
tails to ligation products (Figure 1D).
UTR ligated ORFs were sent to the Macrogen Company
for DNA sequencing. The results demonstrated that all
three genes were cloned with high sequence accuracy
(99.7% for Pdx1, 99.8% for Ngn3, and 99.9% for MafA).
Compared to sequences given in NCBI, in the clones we
constructed there are two nucleotide changes in Pdx1
(resulted in no amino acid change), one nucleotide change
in Ngn3 (resulted in F199S amino acid change), and 1
nucleotide change in MafA (resulted in no amino acid
change).
3.2. In vitro transcription and assessment of modified
mRNAs of Pdx1, Ngn3, and MafA
The quality and quantity of IVT RNAs were assessed
by measuring the OD values using a NanoDrop
spectrophotometer. OD values of all IVT RNA samples
were within the expected ranges: A260/280 ≥ 1.8
and A260/230 ~ 2 (Figure 2A), showing the purity of
synthesized RNAs. The size of IVT RNA fragments was
also assessed by running the samples on a denaturing
agarose gel. The results demonstrated that all IVT RNAs
were of the expected size: 1175 bp for Pdx1, 969 bp for
Ngn3, and 1385 bp for MafA (Figure 2B).
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3.3. Expression of synthesized Pdx1, Ngn3, and MafA
mRNAs in human cells
The expression level of IVT RNAs in human BJ fibroblast
cells was assessed 16 h after their transfection to the
cells. qPCR was performed to see the expression level
of exogenous Pdx1, Ngn3, and MafA RNAs. qPCR data
(Figure 3A) and agarose gel images (Figure 3B) showed
that IVT RNAs can be highly expressed in human cells
even 16 h after transfection.
3.4. In vivo translation of synthesized Pdx1, Ngn3,
and MafA mRNAs and proper localization of their
corresponding proteins in human cells
To demonstrate the proper translation of IVT RNAs in
human fibroblasts cells, western blot (WB) experiments
were performed. The WB results showed that IVT
RNAs were translated properly to their corresponding
proteins (Figure 4A). Moreover, to demonstrate the
proper localization of proteins (PDX1, NGN3, and
MAFA) translated from IVT RNAs in human fibroblast
cells, immunofluorescence (IF) experiments were also
performed. IF images demonstrated that all three proteins
were located properly in the nucleus, which is the final
destination for transcription factors (Figure 4B). Both IF
and WB results showed that protein translation from IVT
RNAs was robust and 16 h after transfection 90.6 ± 2.1%
of Pdx1, 85.4 ± 0.2% of Ngn3, and 83.9 ± 3.3% of MafA
transfected cells could express the proteins of interest
(Figure 5).
3.5. Effect of in vitro synthesized Pdx1, Ngn3, and MafA
mRNAs on human cell viability
Cell viability experiments demonstrated that IVT-modified
Pdx1, Ngn3, and MafA RNAs are not toxic for human cells
for 3 days (Figure 6). In the cell viability experiments
resazurin was given to the cells. In metabolically active
cells resazurin is converted into resorufin, the absorbance
of which can be measured at 560 nm. Dead cells, however,
cannot convert resazurin and give lower absorbance at
560 nm. In Figure 6 it can be seen that absorbance of IVT
RNA-treated cells is equal to that of control (no IVT RNA
treatment) cells and increases over time, indicating that
cells are not dying upon IVT RNA transfection but instead
keep proliferating.
4. Discussion
Ectopic expression of master transcription factors enabled
direct cell reprogramming for many cell types. Upon
discovery of that, especially beta cell reprogramming was
studied intensively. Many studies demonstrated that Pdx1,
Ngn3, and MafA combination, which are indispensable
factors for pancreas and beta cell development, induced
beta cell reprogramming and gave promising results.
However, the disadvantages of the current vectors, used
to ectopically express genes of interest in the target
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RNA assessment & transfection

Figure 1. Construction of dsDNA templates for Pdx1, Ngn3, and MafA. The entire protocol describing the design of dsDNA
templates for Pdx1, Ngn3, and MafA (A). Amplification of ORFs of Pdx1, Ngn3, and MafA by PCR (B). Ligation of 5′ and 3′ UTRs
to ORFs of Pdx1, Ngn3, and MafA (C). Poly(T) addition to UTR ligated ORFs of Pdx1, Ngn3, and MafA through PCR (D). Arrows
indicate the DNA fragments isolated from the gel. M stands for DNA ladder.

cells, necessitate the development of safer strategies for
gene delivery. Construction and transfection of in vitro
synthesized mRNAs is safer than viral vector use and
reduces the risk of foreign DNA recombination into host
genomes, thereby eliminating most of the concerns. In
this study we concentrated our efforts on construction and
production of in vitro-synthesized mRNAs of important
pancreatic transcription factors: Pdx1, Ngn3, and MafA.
First we constructed double strand DNA templates
from which synthetic mRNAs will be transcribed in vitro.
PCR amplification of ORFs and UTR ligated fragments
resulted in nonspecific PCR products in addition to
expected fragments (Figures 1B and 1C). This was due to
limited primer designing opportunity during amplification

experiments. Among nonspecific PCR products, the
expected fragments were excised out and purified from
the agarose gel after electrophoresis. Accuracy of these
fragments was verified by DNA sequencing. High
accuracy of cloned sequences was achieved due to the fact
that high fidelity DNA polymerase enzymes were used in
all PCRs.
To demonstrate that DNA constructs that we designed
here can produce high quality IVT RNAs as efficient as
constructs made by others, we compared IVT RNAs that
we made with synthetic GFP mRNA, which was in vitrosynthesized from plasmid pcDNA3.3_NDG, a gift from
Derrick Rossi (Addgene plasmid #26820) (Warren et al.,
2010) (Figure 2).
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Figure 2. Assessing the quality and quantity of in vitro synthesized Pdx1, Ngn3, and MafA RNAs. OD values measured by
spectrophotometer (A) and gel images (B) of in vitro synthesized Pdx1, Ngn3, MafA, and GFP RNAs.

Figure 3. Expression of in vitro synthesized Pdx1, Ngn3, and MafA RNAs in human fibroblast cells. qPCR data (A) indicating
expression fold change of in vitro synthesized Pdx1, Ngn3, and MafA RNAs, which were normalized to Gapdh expression. Error bars
indicate standard errors; n = 3. Gel image of qPCR products (B).

qPCR results demonstrated high expression of
exogenous Pdx1, Ngn3, and MafA. To detect the
expression of exogenous factors only we designed
primers to span ORFs and ligated UTRs. Expression of
all three factors was robust (Figure 3).
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Translation of proteins and their proper localization
were demonstrated by WB and IF (Figure 4). PDX1 protein
was detected as ~40 kDa by using anti-Pdx1 antibody
(Abcam, ab134150) and this result is consistent with images
demonstrated by the manufacturer. NGN3 protein was

AKINCI et al. / Turk J Biol

Figure 4. Translation and proper localization of in vitro synthesized Pdx1, Ngn3, and MafA RNAs in human cells. Western
blotting (A) and immunofluorescence staining (B) of PDX1, NGN3, and MAFA proteins in human fibroblast cells. Bar is 100
µm.

detected as ~30 kDa by using anti-Ngn3 antibody (Abcam,
ab38548). Pinney et al. (2011) also reported NGN3 of the
same size by using the same antibody. MAFA protein was
detected as ~48 kDa by using anti-MafA antibody (Abcam,

ab26405). Kondo et al. (2009) also reported MAFA of the
same size by using the same antibody (Kondo et al., 2009).
In conclusion, here we successfully constructed
recombinant DNA templates at which Pdx1, Ngn3, and
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Figure 5. Transfection and translation efficiency of in vitro
synthesized Pdx1, Ngn3, and MafA RNAs in human fibroblast
cells.

Figure 6. Cell viability assay of human fibroblast cells transfected with in
vitro synthesized Pdx1, Ngn3, and MafA RNAs.

MafA ORFs were ligated to mouse beta globin 3′-UTR and
T7 promoter as well as a strong Kozak sequence including
5′-UTR. Synthetic mRNAs with high quality and quantity
were in vitro transcribed from these constructs. These
IVT RNAs were transfected into the cultured human
cells with high efficiency and no toxicity. IVT RNAs were
properly translated into their corresponding proteins and
localized into the right location. Based on all these results
we concluded that DNA templates constructed here can be

used to generate in vitro-synthesized RNAs of important
pancreatic transcription factors (Pdx1, Ngn3, and MafA)
that can be used in further beta cell reprogramming
studies.
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